Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma.
Sikander Ailawadhi, MD
Advertisement
Articles by Sikander Ailawadhi, MD
FDA approves SC isatuximab-irfc with the CirCLIQ on-body injector, streamlining multiple myeloma care and reducing nursing burden.
Advertisement
Latest Updated Articles
Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple MyelomaSeptember 16th 2026
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Breast Cancer Awareness: An APN on Personalized Care and Survivorship
2
Oral Vitamin C Misses Primary End Point in CCUS but Shows Survival Signal
3
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
4
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
5